Clinical Trial

A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children

Name: A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children — clinical trial record (NCT06151587)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated November 30, 2023 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Summary

Efficacy and Safety Study of QLM3004 in Myopic Children

Trial Details

NCT Number	NCT06151587
Lead Sponsor	Qilu Pharmaceutical Co., Ltd.
Conditions	Myopia
Enrollment	735 participants
Start Date	2023-08-20
Primary Completion	2026-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2023-11-30